JMP Securities Defends Retrophin, Believes It's Well Positioned To Defend Thiola Franchise From Imprimis Pharma Competition
February 23, 2016 at 07:58 AM EST
JMP Securities’ Lisa A Bayko maintained a Market Outperform rating for Retrophin Inc. (NASDAQ: RTRX), with a price target of ...
